NeuroSense Therapeutics Ltd. Increase Decrease Through Share-based Payment Transactions
NeuroSense Therapeutics Ltd. (NRSN) reported Increase Decrease Through Share-based Payment Transactions of $2.96 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2024-04-04
| Period end | Increase Decrease Through Share-based Payment Transactions 6 month | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|---|
| 2023-12-31 | $2.96M 20-F · filed 2024-04-04 | |
| 2023-06-30 | $1.95M 6-K · filed 2023-08-16 | |
| 2022-12-31 | $4.74M 20-F · filed 2024-04-04 | |
| 2022-06-30 | $2.81M 6-K · filed 2023-08-16 | |
| 2021-12-31 | $4.72M 20-F · filed 2024-04-04 | |
| 2021-06-30 | $2.63M 6-K/A · filed 2023-01-19 | |
| 2020-12-31 | $2.06M 20-F · filed 2023-03-22 | |
| 2019-12-31 | $611.00K 20-F · filed 2022-04-14 |